Double Helix Biotechnology Development - Ownership and Business Overview

Life ScienceCompany

Double Helix Biotechnology Development Ownership

Who owns Double Helix Biotechnology Development?

Double Helix Biotechnology Development is owned by The Interpublic Group of Companies. It was acquired on June 26, 2012.

Double Helix Biotechnology Development Business Overview

Where is Double Helix Biotechnology Development headquartered?

Double Helix Biotechnology Development is headquartered in London, United Kingdom.

What sector is Double Helix Biotechnology Development in?

Double Helix Biotechnology Development is a life science company.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 124 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 106 by strategics.

Double Helix Biotechnology Development Ltd.

88 Baker Street,
London, W1U 6TQ
United Kingdom,
+44 20 7299 9830
www.doublehelix.co.uk

Double Helix Biotechnology Development Ltd. is a provider of market research and market access services to the pharmaceutical and medical device industries.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Double Helix Biotechnology Development

Life Science Companies , United Kingdom Companies